BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 28548933)

  • 21. An inflammatory gene signature distinguishes neurofibroma Schwann cells and macrophages from cells in the normal peripheral nervous system.
    Choi K; Komurov K; Fletcher JS; Jousma E; Cancelas JA; Wu J; Ratner N
    Sci Rep; 2017 Mar; 7():43315. PubMed ID: 28256556
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NF1 gene silencing induces upregulation of vascular endothelial growth factor expression in both Schwann and non-Schwann cells.
    Kawachi Y; Maruyama H; Ishitsuka Y; Fujisawa Y; Furuta J; Nakamura Y; Ichikawa E; Furumura M; Otsuka F
    Exp Dermatol; 2013 Apr; 22(4):262-5. PubMed ID: 23528211
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Humanized neurofibroma model from induced pluripotent stem cells delineates tumor pathogenesis and developmental origins.
    Mo J; Anastasaki C; Chen Z; Shipman T; Papke J; Yin K; Gutmann DH; Le LQ
    J Clin Invest; 2021 Jan; 131(1):. PubMed ID: 33108355
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term culture and characterization of human neurofibroma-derived Schwann cells.
    Rosenbaum T; Rosenbaum C; Winner U; Müller HW; Lenard HG; Hanemann CO
    J Neurosci Res; 2000 Sep; 61(5):524-32. PubMed ID: 10956422
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential expression of CCN1/CYR61, CCN3/NOV, CCN4/WISP1, and CCN5/WISP2 in neurofibromatosis type 1 tumorigenesis.
    Pasmant E; Ortonne N; Rittié L; Laurendeau I; Lévy P; Lazar V; Parfait B; Leroy K; Dessen P; Valeyrie-Allanore L; Perbal B; Wolkenstein P; Vidaud M; Vidaud D; Bièche I
    J Neuropathol Exp Neurol; 2010 Jan; 69(1):60-9. PubMed ID: 20010302
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nf1-dependent tumors require a microenvironment containing Nf1+/-- and c-kit-dependent bone marrow.
    Yang FC; Ingram DA; Chen S; Zhu Y; Yuan J; Li X; Yang X; Knowles S; Horn W; Li Y; Zhang S; Yang Y; Vakili ST; Yu M; Burns D; Robertson K; Hutchins G; Parada LF; Clapp DW
    Cell; 2008 Oct; 135(3):437-48. PubMed ID: 18984156
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neurofibromin-deficient Schwann cells secrete a potent migratory stimulus for Nf1+/- mast cells.
    Yang FC; Ingram DA; Chen S; Hingtgen CM; Ratner N; Monk KR; Clegg T; White H; Mead L; Wenning MJ; Williams DA; Kapur R; Atkinson SJ; Clapp DW
    J Clin Invest; 2003 Dec; 112(12):1851-61. PubMed ID: 14679180
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of insulin-like growth-factor-1 receptor (IGF-1R) in peripheral nerve sheath tumors in neurofibromatosis type 1.
    Friedrich RE; Keiner D; Hagel C
    Anticancer Res; 2007; 27(4A):2085-90. PubMed ID: 17649826
    [TBL] [Abstract][Full Text] [Related]  

  • 29. P2RY14 cAMP signaling regulates Schwann cell precursor self-renewal, proliferation, and nerve tumor initiation in a mouse model of neurofibromatosis.
    Patritti Cram J; Wu J; Coover RA; Rizvi TA; Chaney KE; Ravindran R; Cancelas JA; Spinner RJ; Ratner N
    Elife; 2022 Mar; 11():. PubMed ID: 35311647
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The activation of the WNT signaling pathway is a Hallmark in neurofibromatosis type 1 tumorigenesis.
    Luscan A; Shackleford G; Masliah-Planchon J; Laurendeau I; Ortonne N; Varin J; Lallemand F; Leroy K; Dumaine V; Hivelin M; Borderie D; De Raedt T; Valeyrie-Allanore L; Larousserie F; Terris B; Lantieri L; Vidaud M; Vidaud D; Wolkenstein P; Parfait B; Bièche I; Massaad C; Pasmant E
    Clin Cancer Res; 2014 Jan; 20(2):358-71. PubMed ID: 24218515
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Decreased expression of neurofibromin contributes to epithelial-mesenchymal transition in neurofibromatosis type 1.
    Arima Y; Hayashi H; Kamata K; Goto TM; Sasaki M; Kuramochi A; Saya H
    Exp Dermatol; 2010 Aug; 19(8):e136-41. PubMed ID: 20002172
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Challenge of Cancer Genomics in Rare Nervous System Neoplasms: Malignant Peripheral Nerve Sheath Tumors as a Paradigm for Cross-Species Comparative Oncogenomics.
    Carroll SL
    Am J Pathol; 2016 Mar; 186(3):464-77. PubMed ID: 26740486
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The development of cutaneous neurofibromas.
    Jouhilahti EM; Peltonen S; Callens T; Jokinen E; Heape AM; Messiaen L; Peltonen J
    Am J Pathol; 2011 Feb; 178(2):500-5. PubMed ID: 21281783
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro studies of steroid hormones in neurofibromatosis 1 tumors and Schwann cells.
    Fishbein L; Zhang X; Fisher LB; Li H; Campbell-Thompson M; Yachnis A; Rubenstein A; Muir D; Wallace MR
    Mol Carcinog; 2007 Jul; 46(7):512-23. PubMed ID: 17393410
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Specific expression of the neurofibromatosis type 1 gene (NF1) in the hamster Schwann cell.
    Nakamura T; Nemoto T; Arai M; Yamazaki Y; Kasuga T; Gutmann DH; Collins FS; Ishikawa T
    Am J Pathol; 1994 Mar; 144(3):549-55. PubMed ID: 8129040
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heightened CXCR4 and CXCL12 expression in NF1-associated neurofibromas.
    Karaosmanoglu B; Kocaefe ÇY; Söylemezoğlu F; Anlar B; Varan A; Vargel İ; Ayter S
    Childs Nerv Syst; 2018 May; 34(5):877-882. PubMed ID: 29455242
    [TBL] [Abstract][Full Text] [Related]  

  • 37. S100B and neurofibromin immunostaining and X-inactivation patterns of laser-microdissected cells indicate a multicellular origin of some NF1-associated neurofibromas.
    Tucker T; Riccardi VM; Brown C; Fee J; Sutcliffe M; Vielkind J; Wechsler J; Wolkenstein P; Friedman JM
    J Neurosci Res; 2011 Sep; 89(9):1451-60. PubMed ID: 21674567
    [TBL] [Abstract][Full Text] [Related]  

  • 38. NF1 patient missense variants predict a role for ATM in modifying neurofibroma initiation.
    Yu Y; Choi K; Wu J; Andreassen PR; Dexheimer PJ; Keddache M; Brems H; Spinner RJ; Cancelas JA; Martin LJ; Wallace MR; Legius E; Vogel KS; Ratner N
    Acta Neuropathol; 2020 Jan; 139(1):157-174. PubMed ID: 31664505
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic and cellular defects contributing to benign tumor formation in neurofibromatosis type 1.
    Rutkowski JL; Wu K; Gutmann DH; Boyer PJ; Legius E
    Hum Mol Genet; 2000 Apr; 9(7):1059-66. PubMed ID: 10767330
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Does Schwann cell dedifferentiation originate dermal neurofibromas?
    Iribar H; Jaka A; Ormaechea N; Tuneu A; Izeta A; Gutiérrez-Rivera A
    Exp Dermatol; 2016 Nov; 25(11):901-903. PubMed ID: 27303947
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.